Imricor Medical Systems, Inc. (ASX:IMR)
1.475
-0.060 (-3.91%)
Mar 28, 2025, 4:10 PM AEST
Imricor Medical Systems Revenue
In the year 2024, Imricor Medical Systems had annual revenue of $959.42K USD with 55.86% growth. Imricor Medical Systems had revenue of $551.67K in the half year ending December 31, 2024, with 98.40% growth.
Revenue
$959.42K
Revenue Growth
+55.86%
P/S Ratio
213.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
398.75M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 959.42K | 343.86K | 55.86% |
Dec 31, 2023 | 615.57K | -200.44K | -24.56% |
Dec 31, 2022 | 816.01K | 119.74K | 17.20% |
Dec 31, 2021 | 696.27K | -5.89K | -0.84% |
Dec 31, 2020 | 702.16K | 62.46K | 9.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |